NCT07024836 PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
| NCT ID | NCT07024836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College, London |
| Condition | Tuberculosis (TB) |
| Study Type | OBSERVATIONAL |
| Enrollment | 430 participants |
| Start Date | 2025-05-22 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 430 participants in total. It began in 2025-05-22 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is part of a broader programme of work to develop and pilot a randomised-controlled trial of new tests to identify people who will benefit most from preventive treatment for tuberculosis (TB). The aim of the current study is to explore factors affecting patient decisions to start preventive treatment. The specific objectives are to understand how patients make decisions about preventive treatment initiation for TB (stage 1); and to design and conduct a "discrete choice experiment" survey to further evaluate preferences (stage 2).
Eligibility Criteria
Inclusion Criteria: * Adults (aged ≥18 years) who have been tested for latent TB infection in routine clinical services, or are eligible for testing. Eligible people for testing include migrants from countries with high TB incidence (entered UK within 5 years), people with recent contact with a person with TB disease, and people eligible for LTBI screening prior to starting immunosuppression or through occupational health testing. Exclusion Criteria: * Unable to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07024836 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tuberculosis (TB). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07024836 currently recruiting?
Yes, NCT07024836 is actively recruiting participants. Contact the research team at r.gupta@ucl.ac.uk for enrollment information.
Where is the NCT07024836 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT07024836 clinical trial?
NCT07024836 is sponsored by University College, London. The trial plans to enroll 430 participants.